
Opinion|Videos|July 16, 2024
Differentiating Between the Semi-Fluorinated Alkane-Based Therapies for Dry Eye
Selina McGee, OD, FAAO, discusses the role of cyclosporine ophthalmic solution (VEVYE) in the treatment of dry eye disease.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- When do you prefer to use cyclosporine ophthalmic solution, 0.1% (VEVYE)? How are the indications for this drug different from perfluorohexyloctane ophthalmic solution?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Obesity: New definitions and practical implications to know
2
PROSE treatment improves Mackie stage in neurotrophic keratitis in study
3
From Paper to Clinic, Episode 6: The Window to the Brain: OCT and OCTA
4
Takeaways from this week in optometry: July 27- July 31
5

















